263 filings
Page 3 of 14
8-K
kq3llfi2
4 Aug 22
Results of Operations and Financial Condition
7:01am
8-K
jd4by2eqfjo
27 Jun 22
ESSA Pharma Presents Clinical Update on EPI-7386 Monotherapy and Combination Therapy Clinical Development
4:12pm
8-K
25vzy4 n3sl
10 May 22
ESSA Pharma Provides Corporate Update and Reports Financial Results for Clinical and Corporate Highlights
7:07am
8-K
dcksfzdhihf 44ubicc
10 Mar 22
Submission of Matters to a Vote of Security Holders
10:52am
S-8
r6or0n9hrr imm1kr02m
1 Oct 21
Registration of securities for employees
4:15pm
S-3ASR
be20g29u ou
21 Jun 21
Automatic shelf registration
3:31pm
8-K
rlwc3ps
31 Mar 21
ESSA Announces Change to its Board of Directors
12:00am
8-K
g485eu4t
2 Mar 21
Submission of Matters to a Vote of Security Holders
4:51pm
8-K
s65atx
22 Feb 21
Other Events
5:16pm
424B5
6rcuzbx wtrig
18 Feb 21
Prospectus supplement for primary offering
4:58pm
8-K
hvf0708ik k5n5x
16 Feb 21
ESSA Pharma Provides Corporate Update and Reports Financial Results for Recent Clinical and Corporate Highlights
12:00am
424B5
f6s 1iunmq
16 Feb 21
Prospectus supplement for primary offering
12:00am
8-K
6r45sjmei5pc5x
11 Feb 21
Other Events
10:28am
10-Q
fl2utgxosj
11 Feb 21
Quarterly report
7:02am